about
Regenerating proteins and their expression, regulation, and signalingThe role of Reg IV in colorectal cancer, as a potential therapeutic targetInvolvement of the IL-22/REG Ialpha axis in ulcerative colitisThe reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic targetRegIV expression showing specificity to gastrointestinal tract and its potential role in diagnosing digestive tract neuroendocrine tumor.Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer.Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancerIn vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progressionThe role of the REG4 gene and its encoding product in ovarian epithelial carcinomaOncogenic reg IV is a novel prognostic marker for glioma patient survival.REG4 promotes peritoneal metastasis of gastric cancer through GPR37.Regenerating gene (REG) product and its potential clinical usage.Regenerating gene (REG) 1 alpha promotes pannus progression in patients with rheumatoid arthritis.Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer.Attenuated apoptosis response to Fas-ligand in active ulcerative colitis.Comparison of Gene Expression Between Pediatric and Adult Gastric Mucosa with Helicobacter pylori Infection.Up-regulated Reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model.Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.Expression of REG family genes in human inflammatory bowel diseases and its regulation.Effect of oral hepatocyte growth factor gene mediated by attenuated salmonella on 2-, 4-, 6-trinitro-benzene-sulfonic-acid-induced ulcerative colitis in rat.Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers.REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms.
P2860
Q24625407-104E4FFE-9315-4F5A-A5BE-46C88A110D00Q26777750-FD8613EA-E42D-4217-9F6A-1AE35D680732Q28270049-37653197-75B7-465A-970E-5FA4DFB31249Q33510943-6D1AB639-BA74-404E-BC33-4D7129C9CE3EQ33781029-2B99A6C2-8644-4FB3-8E06-A649DE5CC5CCQ33873519-8A604E05-C618-4EC7-8B67-7DF63162AF42Q34469547-19617EC2-FA5B-4DCD-B3A7-E780F96E0C04Q34558744-E33F6F09-BA3E-4530-AA0D-4F941017596EQ35664633-9C8F848B-5FFC-4C1F-B0B2-E4C6B6CECE16Q36300244-0E529219-AF8C-4834-AEC8-C6705FF53D64Q37317423-A172E9C3-B395-4447-8F0F-524E3C5CD77FQ38640617-C8075795-68F1-4A71-8E2B-D2E119B407CAQ39421574-6DB35389-8DF6-47CD-9E0B-A4F618D87963Q39568944-E4B66957-E8C4-4BF3-8064-2D38A2E56036Q39953920-28BCCE89-C6FD-4EFB-BA69-5D472F9D17F3Q41124930-E5529854-AD86-46DA-AAF0-F27CB393B5BBQ41416579-591EFE63-A952-4C8D-A421-C1808C951F92Q44863098-51E9C1B0-1E5C-4E10-9CC6-07387F8C9738Q47160095-87A0C00D-20A6-431C-AFC0-8257BE631311Q50037484-65B4249F-620F-493B-9109-E2B240792E6BQ51746168-E0837F98-75F9-44D7-BC87-DCD5208785C0Q54499438-DD1098AA-8BFF-4CFE-AD39-D3DF4521AF73
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Expression of the REG IV gene in ulcerative colitis.
@ast
Expression of the REG IV gene in ulcerative colitis.
@en
Expression of the REG IV gene in ulcerative colitis.
@nl
type
label
Expression of the REG IV gene in ulcerative colitis.
@ast
Expression of the REG IV gene in ulcerative colitis.
@en
Expression of the REG IV gene in ulcerative colitis.
@nl
prefLabel
Expression of the REG IV gene in ulcerative colitis.
@ast
Expression of the REG IV gene in ulcerative colitis.
@en
Expression of the REG IV gene in ulcerative colitis.
@nl
P2093
P2860
P1476
Expression of the REG IV gene in ulcerative colitis.
@en
P2093
Akira Sekikawa
Apichart Nanakin
Hirokazu Fukui
Hiroshi Hisatsune
Naoki Kanda
Shigehiko Fujii
Takahiro Fujimori
Tsutomu Chiba
Yoshitaka Konda
P2860
P2888
P304
P356
10.1038/LABINVEST.3700507
P50
P577
2007-01-29T00:00:00Z
P5875
P6179
1022548667